J E Hendrickson
Overview
Explore the profile of J E Hendrickson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manrai P, Siddon A, Hager K, Hendrickson J, Keller M, Tormey C
Immunohematology
. 2021 Sep;
37(3):109-112.
PMID: 34591379
Anti-Jk3 is a rare alloantibody to a high-prevalence antigen primarily seen in individuals of Polynesian descent and is associated with a handful of well-established variants of the gene. We report...
2.
Balbuena-Merle R, Hendrickson J
Transfus Clin Biol
. 2019 Mar;
26(2):112-115.
PMID: 30857806
Red blood cell (RBC) alloimmunization is more common in patients with sickle cell disease (SCD) than in any other studied patient population. The high prevalence of RBC alloimmunization is multi-factorial,...
3.
Curtis S, Curtis B, Lee A, Hendrickson J, Lacy J, Podoltsev N
Hematology
. 2017 Dec;
23(7):429-432.
PMID: 29281948
Objectives: We report a case of an 83 year old man who developed oxaliplatin immune-induced syndrome (OIIS) after his 19th cycle of FOLFOX (5FU, leucovorin, oxaliplatin). When oxaliplatin was omitted...
4.
Gehrie E, Roubinian N, Chowdhury D, Brambilla D, Murphy E, Gottschall J, et al.
Vox Sang
. 2017 Dec;
113(2):160-169.
PMID: 29277907
Background And Objectives: Many hospitals require transfusions to be discontinued when vital signs stray from predetermined ranges, regardless of clinical symptoms. Variations in vital signs may be unrelated to transfusion,...
5.
Natarajan P, Santhanakrishnan M, Tormey C, Hendrickson J
Vox Sang
. 2017 Jun;
112(6):598-600.
PMID: 28597520
Emerging data in animal models and humans suggest that pathogen-associated and damage-associated molecular patterns variably impact RBC alloantibody formation. In this study, we tested the hypothesis that vaccinations may enhance...
6.
Celli R, Schulz W, Hendrickson J, Tormey C
Vox Sang
. 2017 Mar;
112(5):469-472.
PMID: 28337751
We hypothesized that diagnoses may be associated with alloantibody 'responder' status and examined associations between disease states and alloimmunization. Patients with ≥1 alloantibody and non-alloimmunized controls were analysed. Pearson's coefficients...
7.
Cheng C, Tormey C, Hendrickson J
Vox Sang
. 2017 Jan;
112(2):185-186.
PMID: 28098338
No abstract available.
8.
Roubinian N, Hendrickson J, Triulzi D, Gottschall J, Chowdhury D, Kor D, et al.
Vox Sang
. 2016 Dec;
112(1):56-63.
PMID: 28001313
Background: The concordance of haemovigilance criteria developed for surveillance of transfusion-associated circulatory overload (TACO) with its clinical diagnosis has not been assessed. In a pilot study to evaluate an electronic...
9.
Santhanakrishnan M, Tormey C, Natarajan P, Liu J, Hendrickson J
Vox Sang
. 2016 Mar;
111(1):79-87.
PMID: 26950259
Background And Objectives: Fetuses affected by maternal RBC alloantibodies may have prolonged anaemia after birth, leading one to question whether maternal alloantibody transfer may occur outside the placenta. In response...
10.
Gehrie E, Hendrickson J, Tormey C
Vox Sang
. 2015 Jul;
109(4):353-8.
PMID: 26174450
Background And Objectives: One of the challenges surrounding blood component administration is the determination of an appropriate rate of infusion. There are very few evidence-based guidelines available to guide healthcare...